Effects of Pramlintide on Endogenous Production of VLDL Triglyceride and Glucose in the Post Prandial State in Type 2 Diabetes Mellitus.

Trial Profile

Effects of Pramlintide on Endogenous Production of VLDL Triglyceride and Glucose in the Post Prandial State in Type 2 Diabetes Mellitus.

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 15 Dec 2016

At a glance

  • Drugs Pramlintide (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 04 Jun 2012 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
    • 04 Jun 2012 Additional lead trial centre(University of Maryland) identified as reported by ClinicalTrials.gov.
    • 04 Jun 2012 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top